Cited by 701Drug Transport and Resistance MechanismsCholesterol and Lipid MetabolismLiver physiology and pathology

The DOI matches its Crossref record; 170 of the 170 references it cites were found in a registry or an index.

Bile acid receptors as targets for drug development

Open access

Schaap, Frank G., Trauner, Michael, Jansen, Peter L. M.·2014·Nature Reviews Gastroenterology & Hepatology

DOI 10.1038/nrgastro.2013.151

Open this paper in CoChat — free account

Abstract

The intracellular nuclear receptor farnesoid X receptor and the transmembrane G protein-coupled receptor TGR5 respond to bile acids by activating transcriptional networks and/or signalling cascades. These cascades affect the expression of a great number of target genes relevant for bile acid, cholesterol, lipid and carbohydrate metabolism, as well as genes involved in inflammation, fibrosis and carcinogenesis. Pregnane X receptor, vitamin D receptor and constitutive androstane receptor are additional nuclear receptors that respond to bile acids, albeit to a more restricted set of species of bile acids. Recognition of dedicated bile acid receptors prompted the development of semi-synthetic bile acid analogues and nonsteroidal compounds that target these receptors. These agents hold promise to become a new class of drugs for the treatment of chronic liver disease, hepatocellular cancer and extrahepatic inflammatory and metabolic diseases. This Review discusses the relevant bile acid receptors, the new drugs that target bile acid signalling and their possible applications.

Integrity signals

Registry

Crossref · 10.1038/nrgastro.2013.151

Cites

170 of 170 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Bile salt biotransformations by human intestinal bacteria
Ridlon, J. M., Kang, D.-J., & Hylemon, P. B. (2006) · Journal of Lipid Research · doi:10.1194/jlr.r500013-jlr200 · Cited by 2,829
Identification of a nuclear receptor for bile acids
Makishima, M., Okamoto, A. Y., Repa, J. J., Tu, H., Learned, R. M., Luk, A., Hull, M. V., Lustig, K. D., Mangelsdorf, D. J., & Shan, B. (1999) · Science · doi:10.1126/science.284.5418.1362 · Cited by 2,714
Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist
Sayin, S. I., Wahlström, A., Felin, J., Jäntti, S., Marschall, H.-U., Bamberg, K., Angelin, B., Hyötyläinen, T., Orešič, M., & Bäckhed, F. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.01.003 · Cited by 2,331
Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation
Watanabe, M., Houten, S. M., Mataki, C., Christoffolete, M. A., Kim, B. W., Sato, H., Messaddeq, N., Harney, J. W., Ezaki, O., Kodama, T., et al. (2006) · Nature · doi:10.1038/nature04330 · Cited by 2,220
The Enzymes, Regulation, and Genetics of Bile Acid Synthesis
Russell, D. W. (2003) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.72.121801.161712 · Cited by 2,069
A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis
Goodwin, B., Jones, S. A., Price, R. R., Watson, M. A., McKee, D. D., Moore, L. B., Galardi, C., Wilson, J. G., Lewis, M. C., Roth, M. E., et al. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00051-4 · Cited by 1,940
TGR5-Mediated Bile Acid Sensing Controls Glucose Homeostasis
Thomas, C., Gioiello, A., Noriega, L., Strehle, A., Oury, J., Rizzo, G., Macchiarulo, A., Yamamoto, H., Mataki, C., Pruzanski, M., et al. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.08.001 · Cited by 1,885
Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis
Inagaki, T., Choi, M., Moschetta, A., Peng, L., Cummins, C. L., McDonald, J. G., Luo, G., Jones, S. A., Goodwin, B., Richardson, J. A., et al. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.09.001 · Cited by 1,865
EASL Clinical Practice Guidelines: management of cholestatic liver diseases
European Association for the Study of the Liver (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.04.009 · Cited by 1,729
A G Protein-coupled Receptor Responsive to Bile Acids
Kawamata, Y., Fujii, R., Hosoya, M., Harada, M., Yoshida, H., Miwa, M., Fukusumi, S., Habata, Y., Itoh, T., Shintani, Y., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209706200 · Cited by 1,628

Show all 170 references

Research works printed but not linked: 1

van Dijk, R., Kremer, A. F., Enemuo, V., Jansen, P. L., Beuers, U. Clinical and molecular aspects of rifampicin-mediated attenuation of severe persistent hepatocellular secretory failure. Hepatology 56, 549A (2012).

Sorted by citations

Items 201–300 of 701

Alterations in Bile Acid Metabolism Associated With Inflammatory Bowel Disease
Li, N., Zhan, S., Tian, Z., Liu, C., Xie, Z., Zhang, S., Chen, M., Zeng, Z., & Zhuang, X. (2021) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izaa342 · Cited by 60
Nuclear Receptors as Multiple Regulators of NLRP3 Inflammasome Function
Alatshan, A., & Benkő, S. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.630569 · Cited by 58
Optical biosensor based on liquid crystal droplets for detection of cholic acid
Niu, X., Luo, D., Chen, R., Wang, F., Sun, X. W., & Dai, H. (2016) · Optics Communications · doi:10.1016/j.optcom.2016.07.016 · Cited by 57
Characterization of AQPs in Mouse, Rat, and Human Colon and Their Selective Regulation by Bile Acids
Yde, J., Keely, S. J., Wu, Q., Borg, J. F., Lajczak, N., O’Dwyer, A. M., Dalsgaard, P., Fenton, R. A., & Moeller, H. B. (2016) · Frontiers in Nutrition · doi:10.3389/fnut.2016.00046 · Cited by 57
Biliary effects of liraglutide and sitagliptin, a 12‐week randomized placebo‐controlled trial in type 2 diabetes patients
Smits, M. M., Tonneijck, L., Muskiet, M. H. A., Hoekstra, T., Kramer, M. H. H., Diamant, M., Nieuwdorp, M., Groen, A. K., Cahen, D. L., & van Raalte, D. H. (2016) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12748 · Cited by 56
Nuclear Receptor Metabolism of Bile Acids and Xenobiotics: A Coordinated Detoxification System with Impact on Health and Diseases
Garcia, M., Thirouard, L., Sèdes, L., Monrose, M., Holota, H., Caira, F., Volle, D. H., & Beaudoin, C. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113630 · Cited by 58
A Gut-Restricted Lithocholic Acid Analog as an Inhibitor of Gut Bacterial Bile Salt Hydrolases
Adhikari, A. A., Ramachandran, D., Chaudhari, S. N., Powell, C. E., Li, W., McCurry, M. D., Banks, A. S., & Devlin, A. S. (2021) · ACS Chemical Biology · doi:10.1021/acschembio.1c00192 · Cited by 56
Dysregulation of Bile Acids, Lipids, and Nucleotides in Psoriatic Arthritis Revealed by Unbiased Profiling of Serum Metabolites
Paine, A., Brookes, P. S., Bhattacharya, S., Li, D., García-Hernández, M. D. L. L., Tausk, F., & Ritchlin, C. T. (2022) · Arthritis & Rheumatology · doi:10.1002/art.42288 · Cited by 57
Bile Acids and GPBAR-1: Dynamic Interaction Involving Genes, Environment and Gut Microbiome
Portincasa, P., Ciaula, A. D., Garruti, G., Vacca, M., Angelis, M. D., & Wang, D. Q. ‐. (2020) · Nutrients · doi:10.3390/nu12123709 · Cited by 56
Gut Microbiome Regulation of Gut Hormone Secretion
Chao, J. L., Coleman, R. A., Keating, D. J., & Martin, A. M. (2025) · Endocrinology · doi:10.1210/endocr/bqaf004 · Cited by 60
Reciprocal interactions between bile acids and gut microbiota in human liver diseases
Ikegami, T., & Honda, A. (2017) · Hepatology Research · doi:10.1111/hepr.13001 · Cited by 54
Amino sulfonic acids, peptidosulfonamides and other related compounds
Grygorenko, O. O., Biitseva, A. V., & Zhersh, S. (2018) · Tetrahedron · doi:10.1016/j.tet.2018.01.033 · Cited by 58
Treatment of Pruritus Secondary to Liver Disease
Düll, M. M., & Kremer, A. E. (2019) · Current Gastroenterology Reports · doi:10.1007/s11894-019-0713-6 · Cited by 53
Nutrition and Gastrointestinal Microbiota, Microbial-Derived Secondary Bile Acids, and Cardiovascular Disease
Rodríguez-Morató, J., & Matthan, N. R. (2020) · Current Atherosclerosis Reports · doi:10.1007/s11883-020-00863-7 · Cited by 54
Bile Acids Improve Psoriasiform Dermatitis through Inhibition of IL-17A Expression and CCL20-CCR6–Mediated Trafficking of T Cells
Shi, Z., Wu, X., Wu, C., Singh, S. P., Law, T., Yamada, D., Huynh, M., Liakos, W., Yang, G., Farber, J. M., et al. (2021) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2021.10.027 · Cited by 54
The interaction of bile acids and gut inflammation influences the pathogenesis of inflammatory bowel disease
Ciaula, A. D., Bonfrate, L., Khalil, M., & Portincasa, P. (2023) · Internal and Emergency Medicine · doi:10.1007/s11739-023-03343-3 · Cited by 53
Spexin Acts as Novel Regulator for Bile Acid Synthesis
Lin, C., Zhao, L., Huang, T., Lü, L., Khan, M., Liu, J., Zhong, L. L. D., Cai, Z., Fan, B., Wong, A., et al. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00378 · Cited by 53
Protective Effects of Bile Acids Against Hepatic Lipid Accumulation in Hybrid Grouper Fed a High-Lipid Diet
Xu, J., Li, X., Yao, X., Xie, S., Chi, S., Zhang, S., Cao, J., & Tan, B. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.813249 · Cited by 51
Serum Metabolomics and Incidence of Atrial Fibrillation (from the Atherosclerosis Risk in Communities Study)
Alonso, Á., Yu, B., Sun, Y. V., Chen, L. Y., Loehr, L. R., O’Neal, W. T., Soliman, E. Z., & Boerwinkle, E. (2019) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2019.03.017 · Cited by 52
The association between gut microbiota development and maturation of intestinal bile acid metabolism in the first 3 y of healthy Japanese infants
Tanaka, M., Sanefuji, M., Morokuma, S., Yoden, M., Momoda, R., Sonomoto, K., Ogawa, M., Kato, K., & Nakayama, J. (2019) · Gut Microbes · doi:10.1080/19490976.2019.1650997 · Cited by 51
Bile acid metabolism and signaling: Emerging pharmacological targets of dietary polyphenols
Tveter, K. M., Mezhibovsky, E., Wu, Y., & Roopchand, D. E. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108457 · Cited by 52
Gut Microbiota of Nonalcoholic Fatty Liver Disease
Abdou, R., Zhu, L., Baker, R. D., & Baker, S. S. (2016) · Digestive Diseases and Sciences · doi:10.1007/s10620-016-4045-1 · Cited by 52
Bile acids, FGF15/19 and liver regeneration: From mechanisms to clinical applications
Álvarez‐Sola, G., Uriarte, I., Latasa, M. U., Jiménez, M., Bárcena‐Varela, M., Santamaría, E., Urtasun, R., Rodríguez‐Ortigosa, C. M., Prìeto, J., Berraondo, P., et al. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.06.025 · Cited by 54
The role of bile acids in regulating glucose and lipid metabolism
Yu, H., Nie, R., & Shen, C. (2023) · Endocrine Journal · doi:10.1507/endocrj.ej22-0544 · Cited by 52
Quantitative High-Throughput Profiling of Environmental Chemicals and Drugs that Modulate Farnesoid X Receptor
Hsu, C.-W., Zhao, J., Huang, R., Hsieh, J., Hamm, J. T., Chang, X., Houck, K. A., & Xia, M. (2014) · Scientific Reports · doi:10.1038/srep06437 · Cited by 49
Oral delivery of a therapeutic gene encoding glucagon-like peptide 1 to treat high fat diet-induced diabetes
Nurunnabi, M., Lee, S., Revuri, V., Hwang, Y. H., Kang, S. H., Lee, M., Cho, S., Cho, K.-J., Byun, Y., Bae, Y. H., et al. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.08.035 · Cited by 49
Bile Acids, FXR, and Metabolic Effects of Bariatric Surgery
Noel, O. F., Still, C. D., Argyropoulos, G. A., Edwards, M. A., & Gerhard, G. S. (2016) · Journal of Obesity · doi:10.1155/2016/4390254 · Cited by 48
Review article: diagnosis and management of intestinal failure‐associated liver disease in adults
Bond, A., Huijbers, A., Pironi, L., Schneider, S. M., Wanten, G. J. A., & Lal, S. (2019) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.15432 · Cited by 48
The crucial role of bile acids in the entry of porcine enteric calicivirus
Shivanna, V., Kim, Y., & Chang, K. (2014) · Virology · doi:10.1016/j.virol.2014.04.002 · Cited by 47
Gut microbiota and their metabolites in the progression of non-alcoholic fatty liver disease
Zhou, J., Tripathi, M., Sinha, R. A., Singh, B. K., & Yen, P. M. (2021) · Hepatoma Research · doi:10.20517/2394-5079.2020.134 · Cited by 49
Gut Microbiota and Its Metabolite Deoxycholic Acid Contribute to Sucralose Consumption-Induced Nonalcoholic Fatty Liver Disease
Shi, Z., Chen, G., Cao, Z., Wu, F., Lei, H., Chen, C., Song, Y., Liu, C., Li, J., Zhou, J., et al. (2021) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.0c07467 · Cited by 47
Synergistic anti-inflammatory effect of gut microbiota and lithocholic acid on liver fibrosis
Shao, J., Ge, T., Tang, C., Wang, G., Pang, L., & Chen, Z. (2022) · Inflammation Research · doi:10.1007/s00011-022-01629-4 · Cited by 47
A Physiology-Based Model of Bile Acid Distribution and Metabolism Under Healthy and Pathologic Conditions in Human Beings
Voronova, V., Sokolov, V. V., Al-Khaifi, A., Straniero, S., Kumar, C., Peskov, K. V., Helmlinger, G., Rudling, M. J., & Angelin, B. (2020) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2020.02.005 · Cited by 47
Novel Therapeutic Targets in Liver Fibrosis
Zhang, J., Liu, Q., He, J., & Li, Y. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.766855 · Cited by 48
The role of bile salts in liver regeneration
van de Laarschot, L. F. M., Jansen, P. L. M., Schaap, F. G., & Damink, S. W. M. O. (2016) · Hepatology International · doi:10.1007/s12072-016-9723-8 · Cited by 45
Self-citation
Novel bile acid therapeutics for the treatment of chronic liver diseases
Hegade, V. S., Speight, A., Etherington, R. E., & Jones, D. E. (2016) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x16630712 · Cited by 44
Pediatric intestinal failure-associated liver disease
Courtney, C. M., & Warner, B. W. (2017) · Current Opinion in Pediatrics · doi:10.1097/mop.0000000000000484 · Cited by 44
FXR agonist obeticholic acid induces liver growth but exacerbates biliary injury in rats with obstructive cholestasis
van Golen, R. F., Olthof, P. B., Lionarons, D. A., Reiniers, M. J., Alles, L. K., Uz, Z., de Haan, L. R., Ergin, B., de Waart, D. R., Maas, M. A. W., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-33070-1 · Cited by 45
Self-citation
Dietary (poly)phenols mitigate inflammatory bowel disease: Therapeutic targets, mechanisms of action, and clinical observations
Jamieson, P. E., Carbonero, F. G., & Stevens, J. F. (2023) · Current Research in Food Science · doi:10.1016/j.crfs.2023.100521 · Cited by 49
Farnesoid X receptor–induced lysine‐specific histone demethylase reduces hepatic bile acid levels and protects the liver against bile acid toxicity
Kim, Y., Fang, S., Byun, S., Seok, S., KEMPER, B. W., & Kemper, J. K. (2014) · Hepatology · doi:10.1002/hep.27677 · Cited by 44
Microbiota and the liver
Shen, T. D., Pyrsopoulos, N., & Rustgi, V. K. (2018) · Liver Transplantation · doi:10.1002/lt.25008 · Cited by 44
Ursodeoxycholic Acid Alters Bile Acid and Fatty Acid Profiles in a Mouse Model of Diet-Induced Obesity
Zhang, Y., Zheng, X., Huang, F., Zhao, A., Ge, K., Zhao, Q., & Jia, W. P. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00842 · Cited by 43
The Liver under the Spotlight: Bile Acids and Oxysterols as Pivotal Actors Controlling Metabolism
Lefort, C., & Cani, P. D. (2021) · Cells · doi:10.3390/cells10020400 · Cited by 44
Detection of bile acids using optical biosensors based on cholesteric liquid crystal droplets
Gollapelli, B., Tatipamula, A. K., Dewanjee, S., Pathinti, R. S., & Vallamkondu, J. (2021) · Journal of Materials Chemistry C · doi:10.1039/d1tc02801d · Cited by 43
Bile acid metabolism and FXR-mediated effects in human cholestatic liver disorders
Molinaro, A., & Marschall, H. (2022) · Biochemical Society Transactions · doi:10.1042/bst20210658 · Cited by 44
Gut microbiota-modulating agents in alcoholic liver disease: Links between host metabolism and gut microbiota
Jung, J. H., Kim, S. E., Suk, K. T., & Kim, D. J. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.913842 · Cited by 42
Integrating multi-omics data to reveal the host-microbiota interactome in inflammatory bowel disease
Su, F., Su, M., Wei, W., Wu, J., Chen, L., Sun, X., Liu, M., Sun, S., Mao, R., Bourgonje, A. R., et al. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2476570 · Cited by 43
Metabolomics and Incidence of Atrial Fibrillation in African Americans: The Atherosclerosis Risk in Communities (ARIC) Study
Alonso, Á., Yu, B., Qureshi, W., Grams, M. E., Selvin, E., Soliman, E. Z., Loehr, L. R., Chen, L. Y., Agarwal, S. K., Alexander, D. C., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0142610 · Cited by 42
Lessons from Hepatocyte-Specific Cyp51 Knockout Mice: Impaired Cholesterol Synthesis Leads to Oval Cell-Driven Liver Injury
Lorbek, G., Perše, M., Jeruc, J., Juvan, P., Gutierrez-Mariscal, F. M., Lewińska, M., Gebhardt, R., Keber, R., Horvat, S., Björkhem, I., et al. (2015) · Scientific Reports · doi:10.1038/srep08777 · Cited by 42
Newer Approaches to the Management of Pruritus in Cholestatic Liver Disease
Düll, M. M., & Kremer, A. E. (2020) · Current Hepatology Reports · doi:10.1007/s11901-020-00517-x · Cited by 42
The Role of Gut Microbiota-Bile Acids Axis in the Progression of Non-alcoholic Fatty Liver Disease
Ni, Y., Lu, M., Xu, Y., Wang, Q., Gu, X., Li, Y., Zhuang, T., Xia, C., Zhang, T., Gou, X., et al. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.908011 · Cited by 45
Inter-organ Communication in the Regulation of Lipid Metabolism: Focusing on the Network Between the Liver, Intestine, and Heart
Ito, M., & Adachi‐Akahane, S. (2013) · Journal of Pharmacological Sciences · doi:10.1254/jphs.13r09cp · Cited by 41
Novel Pharmacotherapy Options for NASH
Ratziu, V. (2016) · Digestive Diseases and Sciences · doi:10.1007/s10620-016-4128-z · Cited by 43
Liver infiltrating T cells regulate bile acid metabolism in experimental cholangitis
Glaser, F., John, C., Engel, B., Hoeh, B., Weidemann, S. A., Dieckhoff, J., Stein, S., Becker, N., Casar, C., Schuran, F. A., et al. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.05.030 · Cited by 41
The intestinal microbiome and paediatric liver disease
Leung, D. H., & Yimlamai, D. (2017) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(16)30241-2 · Cited by 40
Cholestasis-Associated Pruritus and Its Pruritogens
Langedijk, J., Beuers, U. H., & Elferink, R. P. J. O. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.639674 · Cited by 44
Bile Acid Sequestrants for Hypercholesterolemia Treatment Using Sustainable Biopolymers: Recent Advances and Future Perspectives
Islam, M. S., Sharif, A., Kwan, N., & Tam, K. C. (2022) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.2c00007 · Cited by 40
Sarcopenia Induced by Chronic Liver Disease in Mice Requires the Expression of the Bile Acids Membrane Receptor TGR5
Ábrigo, J., Campos, F., Gonzalez, F., Aguirre, F. S., González, A., Huerta-Salgado, C., Conejeros-Lillo, S., Simón, F., Arrese, M. A., Cabrera, D., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21217922 · Cited by 40
Farnesoid X Receptor Agonists and Other Bile Acid Signaling Strategies for Treatment of Liver Disease
Halilbasic, E., Fuchs, C. D., Traussnigg, S., & Trauner, M. (2016) · Digestive Diseases · doi:10.1159/000445268 · Cited by 39
Self-citation
Serum metabolomics analysis reveals that obvious cardioprotective effects of low dose Sini decoction against isoproterenol-induced myocardial injury in rats
Zhou, J. F., Ma, X., Shi, M., Chen, C., Sun, Y., Li, J., Xiong, Y., Chen, J., & Li, F. (2017) · Phytomedicine · doi:10.1016/j.phymed.2017.01.009 · Cited by 39
Gut microbial composition can differentially regulate bile acid synthesis in humanized mice
Kang, D. J., Hylemon, P. B., Gillevet, P. M., Sartor, R. B., Betrapally, N. S., Kakiyama, G., Sikaroodi, M., Takei, H., Nittono, H., Zhou, H., et al. (2017) · Hepatology Communications · doi:10.1002/hep4.1020 · Cited by 40
Bile acid changes after metabolic surgery are linked to improvement in insulin sensitivity
Ahlin, S., CEFALO, C. M. A., Bondia‐Pons, I., Capristo, E., Marini, L., Gastaldelli, A., Mingrone, G., & Nolan, J. J. (2019) · British journal of surgery · doi:10.1002/bjs.11208 · Cited by 39
Comprehensive amelioration of high-fat diet-induced metabolic dysfunctions through activation of the PGC-1α pathway by probiotics treatment in mice
Kwon, J., Kim, B., Lee, C., Joung, H., Kim, B.-K., Choi, I. S., & Hyun, C. (2020) · PLoS ONE · doi:10.1371/journal.pone.0228932 · Cited by 39
Sialyltransferase Inhibitors for the Treatment of Cancer Metastasis: Current Challenges and Future Perspectives
Perez, S. J. L. P., Fu, C., & Li, W. (2021) · Molecules · doi:10.3390/molecules26185673 · Cited by 39
Pathophysiology of Nonalcoholic Fatty Liver Disease: Lifestyle-Gut-Gene Interaction
Mazzotti, A., Caletti, M. T., Sasdelli, A. S., Brodosi, L., & Marchesini, G. (2016) · Digestive Diseases · doi:10.1159/000447275 · Cited by 39
Primary biliary cholangitis: molecular pathogenesis perspectives and therapeutic potential of natural products
Zhao, Y., Wei, S., Chen, L., Zhou, X., & Ma, X. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1164202 · Cited by 38
Beneficial effects of bile acid receptor agonists in pulmonary disease models
Comeglio, P., Morelli, A., Adorini, L., Maggi, M., & Vignozzi, L. (2017) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2017.1385760 · Cited by 39
Multifunctional epiberberine mediates multi-therapeutic effects
Liu, L., Li, J., & He, Y. (2020) · Fitoterapia · doi:10.1016/j.fitote.2020.104771 · Cited by 38
Epigenetics in the primary biliary cholangitis and primary sclerosing cholangitis
Cheung, A., LaRusso, N., Gores, G., & Lazaridis, K. (2017) · Seminars in Liver Disease · doi:10.1055/s-0037-1603324 · Cited by 37
Bile acids promote the development of HCC by activating the inflammasome
Chen, W., Ding, M., Ji, L., Yao, J., Guo, Y., Yan, W., Yu, S., Shen, Q., Huang, M., Zheng, Y., et al. (2023) · Hepatology Communications · doi:10.1097/hc9.0000000000000217 · Cited by 37
Gut Microbiota Metabolites: Unveiling Their Role in Inflammatory Bowel Diseases and Fibrosis
Bernardi, F., D’Amico, F., Bencardino, S., Faggiani, I., Fanizza, J., Zilli, A., Parigi, T. L., Allocca, M., Danese, S., & Furfaro, F. (2024) · Pharmaceuticals · doi:10.3390/ph17030347 · Cited by 39
Regulating bile acids signaling for NAFLD: molecular insights and novel therapeutic interventions
Wei, M., Tu, W., & Huang, G. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1341938 · Cited by 39
Gut–Brain Axis and Bile Acid Signaling: Linking Microbial Metabolism to Brain Function and Metabolic Regulation
Stanimirov, B., Đanić, M., Pavlović, N., Zaklan, D., Lazarević, S., Mikov, M., & Stankov, K. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262412167 · Cited by 39
Steroidal Scaffolds as FXR and GPBAR1 Ligands: From Chemistry to Therapeutical Application
Sepe, V., Distrutti, E., Limongelli, V., Fiorucci, S., & Zampella, A. (2015) · Future Medicinal Chemistry · doi:10.4155/fmc.15.54 · Cited by 37
Sex-Related Differences of Lipid Metabolism Induced by Triptolide: The Possible Role of the LXRα/SREBP-1 Signaling Pathway
Jiang, Z., Huang, X., Huang, S., Guo, H., Wang, L., Li, X., Huang, X., Wang, T., Zhang, L., & Sun, L. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00087 · Cited by 37
Bile Acids in Nonalcoholic Fatty Liver Disease: New Concepts and Therapeutic Advances
Cruz-Ramón, V., Chinchilla-López, P., Ramírez-Pérez, O., & Méndez‐Sánchez, N. (2017) · Annals of Hepatology · doi:10.5604/01.3001.0010.5498 · Cited by 37
Altered duodenal bile salt concentration and receptor expression in functional dyspepsia
Beeckmans, D., Riethorst, D., Augustijns, P., Vanuytsel, T., Farré, R., Tack, J. F., & Vanheel, H. (2018) · United European Gastroenterology Journal · doi:10.1177/2050640618799120 · Cited by 36
The pregnane X receptor drives sexually dimorphic hepatic changes in lipid and xenobiotic metabolism in response to gut microbiota in mice
Barretto, S. A., Lasserre, F., Huillet, M., Régnier, M., Polizzi, A., Lippi, Y., Fougerat, A., Person, E., Bruel, S., Bétoulières, C., et al. (2021) · Microbiome · doi:10.1186/s40168-021-01050-9 · Cited by 42
Design of Gut-Restricted Thiazolidine Agonists of G Protein-Coupled Bile Acid Receptor 1 (GPBAR1, TGR5)
Chen, T., Reich, N. W., Bell, N., Finn, P. D., Rodriguez, D. J., Kohler, J. N., Kozuka, K., He, L., Spencer, A. G., Charmot, D., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00308 · Cited by 37
The gut microbiota of nonalcoholic fatty liver disease: current methods and their interpretation
van Best, N., Jansen, P. L. M., & Rensen, S. S. (2015) · Hepatology International · doi:10.1007/s12072-015-9640-2 · Cited by 37
Self-citation
Gut microbial metabolite deoxycholic acid facilitates Th17 differentiation through modulating cholesterol biosynthesis and participates in high-fat diet-associated colonic inflammation
Li, D., Zhou, J., Wang, L., Gong, Z., Le, H., Huang, Y., Xu, C., Tian, C., Cai, W., & Wu, J. (2023) · Cell & Bioscience · doi:10.1186/s13578-023-01109-0 · Cited by 35
Reciprocal interactions between gut microbiota and autophagy
Lapaquette, P., Bizeau, J.-B., Acar, N., & Bringer, M.-A. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i48.8283 · Cited by 38
HORSE SPECIES SYMPOSIUM: Canine intestinal microbiology and metagenomics: From phylogeny to function1
Guard, B. C., & Suchodolski, J. S. (2016) · Journal of Animal Science · doi:10.2527/jas.2015-0029 · Cited by 36
Intermittent Hypoxia and Hypercapnia Reproducibly Change the Gut Microbiome and Metabolome across Rodent Model Systems
Tripathi, A., Xu, Z. Z., Xue, J., Poulsen, O., Gonzalez, A., Humphrey, G., Meehan, M. J., Melnik, A. V., Ackermann, G. L., Zhou, D., et al. (2019) · mSystems · doi:10.1128/msystems.00058-19 · Cited by 36
Contributions of bile acids to gastrointestinal physiology as receptor agonists and modifiers of ion channels
Keely, S. J., Urso, A., Ilyaskin, A. V., Korbmacher, C., Bunnett, N. W., Poole, D. P., & Carbone, S. (2021) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00125.2021 · Cited by 37
Review on chronic metabolic diseases surrounding bile acids and gut microbiota: What we have explored so far
Zhu, Z., Xu, Y., Xia, Y., Jia, X., Chen, Y., Liu, Y., Zhang, L., Chai, H., & Sun, L. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.122304 · Cited by 34
Cross-Species Molecular Imaging of Bile Salts and Lipids in Liver: Identification of Molecular Structural Markers in Health and Disease
Flinders, B., Huizing, L. R. S., van Heerden, M., Cuyckens, F., Neumann, U. P., van der Laan, L. J. W., Damink, S. W. M. O., Heeren, R. M. A., Schaap, F. G., & Vreeken, R. J. (2018) · Analytical Chemistry · doi:10.1021/acs.analchem.8b01378 · Cited by 34
Self-citation
Pruritus secondary to primary biliary cholangitis: a review of the pathophysiology and management with phototherapy
Hussain, A. B., Samuel, R. J., Hegade, V. S., Jones, D. E., & Reynolds, N. J. (2019) · British Journal of Dermatology · doi:10.1111/bjd.17933 · Cited by 34
TGR5 deficiency aggravates hepatic ischemic/reperfusion injury via inhibiting SIRT3/FOXO3/HIF-1ɑ pathway
Wang, Q., Song, W., Li, L., Qiu, J., Zhou, S., Shi, C., Shi, Y., Zhou, H., & Lü, L. (2020) · Cell Death Discovery · doi:10.1038/s41420-020-00347-2 · Cited by 34
Dietary supplementation with aromatic amino acids decreased triglycerides and alleviated hepatic steatosis by stimulating bile acid synthesis in mice
Ma, Q., Chen, J., Zhou, X., Hu, L., Sun, Y., Wang, Z., Yue, Z., & Shan, A. (2020) · Food & Function · doi:10.1039/d0fo02364g · Cited by 34
Inulin accelerates weight loss in obese mice by regulating gut microbiota and serum metabolites
Wu, Z., Du, Z., Tian, Y., Liu, M., Zhu, K., Zhao, Y., & Wang, H. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.980382 · Cited by 33
Gut microbiota and bile acids partially mediate the improvement of fibroblast growth factor 21 on methionine-choline-deficient diet-induced non-alcoholic fatty liver disease mice
Lin, D., Sun, Q., Liu, Z., Pan, J., Zhu, J., Wang, S., Jia, S., Zheng, M., Li, X., & Gong, F. (2022) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2022.12.087 · Cited by 37
The enteric microbiome in hepatobiliary health and disease
Tabibian, J. H., Varghese, C., LaRusso, N. F., & O’Hara, S. P. (2015) · Liver International · doi:10.1111/liv.13009 · Cited by 33
Post-hepatectomy liver regeneration in the context of bile acid homeostasis and the gut-liver signaling axis
de Haan, L. R., van der Lely, S. J., Warps, A. K., Hofsink, Q., Olthof, P. B., de Keijzer, M. J., Lionarons, D. A., Dias, L. M., Bruinsma, B. G., Uygun, K., et al. (2018) · Journal of Clinical and Translational Research · doi:10.18053/jctres.04.201801.001 · Cited by 33
Hepatic NAPE-PLD Is a Key Regulator of Liver Lipid Metabolism
Lefort, C., Roumain, M., Hul, M. V., Rastelli, M., Manco, R., Leclercq, I. A., Delzenne, N. M., Marzo, V. D., Flamand, N., Luquet, S. H., et al. (2020) · Cells · doi:10.3390/cells9051247 · Cited by 33
Targeting bile acid signaling for the treatment of liver diseases: From bench to bed
Duan, S., Li, X., Fan, G., & Liu, R. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113154 · Cited by 33
A metabolomic perspective of griseofulvin-induced liver injury in mice
Liu, K., Yan, J., Sachar, M., Zhang, X., Guan, M., Xie, W., & Ma, X. (2015) · Biochemical Pharmacology · doi:10.1016/j.bcp.2015.09.002 · Cited by 33
Effects of plant natural products on metabolic-associated fatty liver disease and the underlying mechanisms: a narrative review with a focus on the modulation of the gut microbiota
Cai, T., Song, X., Xu, X., Dong, L., Liang, S., Xin, M., Huang, Y., Zhu, L., Li, T., Wang, X., et al. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1323261 · Cited by 32
Systems Biology Approaches for Inflammatory Bowel Disease
Moco, S., Candela, M., Chuang, E., Draper, C. F., Cominetti, O., Montoliu, I., Barron, D., Kussmann, M., Brigidi, P., Gionchetti, P., et al. (2014) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000116 · Cited by 34
The cholic acid extension study in Zellweger spectrum disorders: Results and implications for therapy
Klouwer, F. C. C., Koot, B. G. P., Berendse, K., Kemper, E. M., Ferdinandusse, S., Koelfat, K. V. K., Leníček, M., Vaz, F. M., Engelen, M., Jansen, P. L. M., et al. (2018) · Journal of Inherited Metabolic Disease · doi:10.1002/jimd.12042 · Cited by 32
Self-citation

Authors: Schaap, F. G., Trauner, M., & Jansen, P. L. M.
Affiliations: Maastricht University (NL)
Medical University of Vienna (AT)
Amsterdam UMC Location University of Amsterdam (NL)
Corresponding author: Jansen, Peter L. M.
ORCID: Schaap, Frank G.
Trauner, Michael
Venue: Nature Reviews Gastroenterology & Hepatology
Publisher: Springer Science and Business Media LLC
Published: 2013-08-27
Volume: 11
Issue: 1
Pages: 55-67
ISSN: 1759-5045 (ISSN-L)
1759-5053
DOI: 10.1038/nrgastro.2013.151
OpenAlex: W2022279737
Cited by: 696
References: 170
Citations by year: 2026: 40 · 2025: 36 · 2024: 50 · 2023: 58 · 2022: 74 · 2021: 80 · 2020: 67 · 2019: 61 · 2018: 62 · 2017: 49 · 2016: 56 · 2015: 32 · 2014: 30 · 2013: 1
FWCI: 4.27
Type: journal article
Language: en
Open access: green
zenodo.org
Licence: other-oa
www.springer.com/tdm (tdm)
Locations: Nature Reviews Gastroenterology & Hepatology (publishedVersion)
PubMed (publishedVersion)
Pure Amsterdam UMC (publishedVersion)
Data Archiving and Networked Services (DANS) (submittedVersion)
Research Publications (Maastricht University) (submittedVersion)
Zenodo (CERN European Organization for Nuclear Research) (submittedVersion, other-oa)
Funders: CYTED Ciencia y Tecnología para el Desarrollo
Topics: Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
Health Sciences › Medicine › Hepatology › Liver physiology and pathology
Keywords: bile acid receptors, bile acid signaling, farnesoid X receptor, TGR5, G protein-coupled receptors, nuclear receptors, pregnane X receptor, vitamin D receptor, constitutive androstane receptor, bile acid analogues, drug development, chronic liver disease, hepatocellular carcinoma, inflammation, fibrosis, metabolic disorders, cholesterol metabolism
MeSH terms: Animals, Bile Acids and Salts, Disease Models, Animal, Drug Therapy, Humans, Inflammation, Liver Diseases, Liver Neoplasms, Metabolic Diseases, Signal Transduction, Receptors, Cytoplasmic and Nuclear, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Bile acid receptors as targets for drug development

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks